Ahmet BOZDAĞ, Pınar GÜNDOĞAN BOZDAĞ, Gülden ESER KARLIDAĞ, Mehmet KALAYCI

Does liver density change in computed tomography in COVID-19 patients?

Aim: Corona virus disease 2019 (COVID-19) mainly affects the lungs. However, other organs are affected as well. This article aimed to evaluate the effects of coronavirus infection on liver density in addition to the laboratory findings. Materials and Methods: Biochemical parameters and non-contrast tomography images of the patients who presented to the pandemic clinic were studied retrospectively. Densities of the right and left lobes of the liver were measured. Patients were divided into two groups according to the results of polymerase chain reaction (PCR) tests. Results: Our study included 117 PCR (+) and 66 PCR (-) patients. Statistical comparison of the two groups revealed a significant difference in age, densities of the right and left lobes of the liver, and aspartate aminotransferase, gammaglutamyl transferase, total bilirubin, and lactate dehydrogenase values (p < 0.05). According to the correlation test, there was a negative correlation between the densities of the right and left lobes of the liver and transaminases. Conclusion: An inverse relationship emerged between liver density and transaminases. Therefore, liver functions should be monitored more closely in COVID-19 patients during treatment, and if it is at high levels, treatment should be started early.

PDF

___

1. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. doi: 10.1016/S0140-6736(20)30183-5.
2. Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069. doi: 10.1001/jama.2020.1585.
3. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5: 428–430. doi: 10.1016/S2468-1253(20)30057-1.
4. Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: Its impact on liver disease and liver transplantation. World J Gastroenterol. 2020;26(22):2987-2999.
5. Shi H, Han X, Jiang N et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 20: 425–434. doi: 10.1016/S1473-3099(20)30086-4.
6. Lei P, Zhang L, Han P et al. Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury. Hepatol Int 2020; 14: 733–742. doi: 10.1007/s12072-020-10087-1.
7. Altunisik Toplu S, Bayindir Y, Yilmaz S et al. Short-term experiences of a liver transplant centre before and after the COVID-19 pandemic. Int J Clin Pract. 2021;75(10):e14668.
8. Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: etiology, treatment and prognosis. World J Gastroenterol 2020; 26: 2286–2293. doi: 10.3748/wjg.v26.i19.2286.
9. Feng G, Zheng KI, Yan QQ et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol 2020; 8: 18–24. doi: 10.14218/JCTH.2020.00018.
10. Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507– 513. doi: 10.1016/S0140-6736(20)30211-7.
11. Liu C, Jiang ZC, Shao CX et al. Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study. Zhonghua Gan Zang Bing Za Zhi 2020; 28: 107–111. doi: 10.3760/cma.j.issn.1007- 3418.2020.02.003.
12. Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med 2020; published online February 28. doi: 10.1056/NEJMoa2002032.
13. Hoffmann M, Kleine-Weber H, Krüger N et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-1 coronavirus receptor 2 ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv 2020; in press. doi: 10.1101/2020.01.31.929042.
14. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020; in press. doi: 10.1101/2020.02.03.931766.
15. Tuncer A, Akbulut S, Baskiran A et al. A Recipient and Donor Both Have COVID-19 Disease. Should We Perform a Liver Transplant? J Gastrointest Cancer. 2021;52(3):1143-1147.
16. Xu Z, Shi L,Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420–422. doi: 10.1016/S2213-2600(20)30076-X.
17. Yang Z, Xu M, Yi JQ, Jia WD. Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. Hepatobiliary Pancreat Dis Int 2005; 4: 60–63.
18. Liu J, Li S, Liu J et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020; 102763. doi: 10.1101/2020.02.16.20023671. 558